Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Lecart

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Revue Medicale De Liege|January 1, 1989
[A years' treatment of Paget's disease of bone using salmon calcitonin via nasal spray]D Denis, M P Lecart, R Deroisy, et al.
The American Journal of Medicine|May 1, 1995
A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone lossJ Y Reginster, R Deroisy, M P Lecart, et al.
Drugs & Aging|May 7, 2014
Antiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosisJ Y Reginster, A Neuprez, C Beaudart, et al.
Lancet (London, England)|December 26, 1987
1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitoninJ Y Reginster, D Denis, A Albert, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1994
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJ Y Reginster, D Denis, R Deroisy, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of boneJ Y Reginster, C Gennari, C Mautalen, et al.
Bone|January 1, 1988
Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of boneJ Y Reginster, A M Jeugmans-Huynen, A Albert, et al.
Revue Medicale De Liege|December 15, 1988
[Biological and clinical effects of a new diphosphonate (chloro-4-phenyl) thiomethylene-diphosphonate in Paget's disease of bone]M P Lecart, A M Jeugmans-Huynen, A Albert, et al.
Intensive Care Medicine|January 1, 1987
Thromboxane and prostacyclin release in adult respiratory distress syndromeG Deby-Dupont, M Braun, M Lamy, et al.
Revue Medicale De Liege|April 29, 2004
[Chronic pain management: a multidisciplinary approach]R Fontaine, S Fuchs, R Hardy, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Revue Medicale De Liege|January 1, 1989
[A years' treatment of Paget's disease of bone using salmon calcitonin via nasal spray]D Denis, M P Lecart, R Deroisy, et al.
The American Journal of Medicine|May 1, 1995
A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone lossJ Y Reginster, R Deroisy, M P Lecart, et al.
Drugs & Aging|May 7, 2014
Antiresorptive drugs beyond bisphosphonates and selective oestrogen receptor modulators for the management of postmenopausal osteoporosisJ Y Reginster, A Neuprez, C Beaudart, et al.
Lancet (London, England)|December 26, 1987
1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitoninJ Y Reginster, D Denis, A Albert, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 1, 1994
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJ Y Reginster, D Denis, R Deroisy, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of boneJ Y Reginster, C Gennari, C Mautalen, et al.
Bone|January 1, 1988
Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl) thiomethylene bisphosphonate, in the treatment of Paget's disease of boneJ Y Reginster, A M Jeugmans-Huynen, A Albert, et al.
Revue Medicale De Liege|December 15, 1988
[Biological and clinical effects of a new diphosphonate (chloro-4-phenyl) thiomethylene-diphosphonate in Paget's disease of bone]M P Lecart, A M Jeugmans-Huynen, A Albert, et al.
Intensive Care Medicine|January 1, 1987
Thromboxane and prostacyclin release in adult respiratory distress syndromeG Deby-Dupont, M Braun, M Lamy, et al.
Revue Medicale De Liege|April 29, 2004
[Chronic pain management: a multidisciplinary approach]R Fontaine, S Fuchs, R Hardy, et al.
Pageof 4